Release Date: 07/04/17 12:55 Summary: MCL PIONEERING LAWFUL CANNABIS GENETICS IN AUSTRALIA Price Sensitive: Yes Download Document 530.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%